Evidence map›Paper›PMID 36077265›Full record

ReviewInternational journal of molecular sciences2022

An Eye on Kupffer Cells: Development, Phenotype and the Macrophage Niche.

Andrey Elchaninov, Polina Vishnyakova, Egor Menyailo, Gennady Sukhikh, Timur Fatkhudinov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Liver Macrophages in the Pathogenesis of Viral Hepatitis.Current issues in molecular biology · 2026
    Review
  4. Reprogramming macrophages to treat liver diseases.Hepatology (Baltimore, Md.) · 2026
    Review
  5. Article
  6. Kupffer cells: Orchestrators of liver physiology.Liver research (Beijing, China) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. The authors respond to feedback onFrontiers in oncology · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Liver disorders and phytotherapy.Toxicology reports · 2025
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Andrey ElchaninovLaboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia.ORCID 0000-0002-2392-4439
Polina VishnyakovaLaboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia.ORCID 0000-0001-8650-8240
Egor MenyailoLaboratory of Growth and Development, Avtsyn Research Institute of Human Morphology of FSBI "Petrovsky National Research Centre of Surgery", 117418 Moscow, Russia.ORCID 0000-0002-3511-9779
Gennady SukhikhLaboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia.
Timur FatkhudinovHistology Department, Medical Institute, Peoples' Friendship University of Russia, 117198 Moscow, Russia.ORCID 0000-0002-6498-5764
Peoples' Friendship University of Russia · RUNational Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Healthcare of the Russian Federation · RUPirogov Russian National Research Medical University · RUResearch Institute of Human Morphology · RU

Funding

Ministry of Education and Science of Russia Agreement No. 075-15-2021-1356 dated October 7, 2021 (RF identifier 0951.61321X0012, No. 15.SIN.21.0011)RUDN University Strategic Academic Leadership Program 2030Russian Science Foundation 22-14-00152State Assignment "Development of a method for the treatment of ovarian cancer using macrophages with persistent pro-inflammatoryproperties 121040600409-1
6 · The paper itself

Abstract

Macrophages are key participants in the maintenance of tissue homeostasis under normal and pathological conditions, and implement a rich diversity of functions. The largest population of resident tissue macrophages is found in the liver. Hepatic macrophages, termed Kupffer cells, are involved in the regulation of multiple liver functionalities. Specific differentiation profiles and functional activities of tissue macrophages have been attributed to the shaping role of the so-called tissue niche microenvironments. The fundamental macrophage niche concept was lately shaken by a flood of new data, leading to a revision and substantial update of the concept, which constitutes the main focus of this review. The macrophage community discusses contemporary evidence on the developmental origins of resident macrophages, notably Kupffer cells and the issues of heterogeneity of the hepatic macrophage populations, as well as the roles of proliferation, cell death and migration processes in the maintenance of macrophage populations of the liver. Special consideration is given to interactions of Kupffer cells with other local cell lineages, including Ito cells, sinusoidal endothelium and hepatocytes, which participate in the maintenance of their phenotypical and functional identity.

Indexed as

Kupffer CellsMacrophagesHepatocytesHumansLiverPhenotypeendothelial cellshepatocytesIto cellsKupffer cellsmacrophage nichemacrophagesmonocytes

Identifiers

PMID36077265
PMCPMC9456487
OpenAlexW4293773481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.